Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 30, 2014

Primary Completion Date

July 17, 2017

Study Completion Date

October 1, 2018

Conditions

Solid TumorCancer

Interventions

DRUG

Aspirin

81mg/day for 4 weeks

DRUG

Simvastatin

Daily dose of Simvastatin for 4 weeks

OTHER

Observation

participants will be observed for thrombotic evens for 4 weeks

Trial Locations (1)

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors

lead

Case Comprehensive Cancer Center

OTHER

NCT02285738 - Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | Biotech Hunter | Biotech Hunter